{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:35:52Z","timestamp":1771655752518,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"DOI":"10.1007\/s10456-013-9402-5","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T14:49:51Z","timestamp":1382539791000},"source":"Crossref","is-referenced-by-count":14,"title":["Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A"],"prefix":"10.1007","author":[{"given":"Aling","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Snell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savira","family":"Ekawardhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia K. J.","family":"Ahlskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jikui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"F. Hackett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Stumpp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"A. Campochiaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"9402_CR1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00006982-200110000-00003","volume":"21","author":"LA Yannuzzi","year":"2001","unstructured":"Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter JS, Freund KB, Sorenson J, Orlock D, Borodoker N (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416\u2013434","journal-title":"Retina"},{"key":"9402_CR2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00109-013-0993-5","volume":"91","author":"PA Campochiaro","year":"2013","unstructured":"Campochiaro PA (2013) Ocular neovascularization. J Mol Med 91:311\u2013321","journal-title":"J Mol Med"},{"key":"9402_CR3","first-page":"3158","volume":"41","author":"N Kwak","year":"2000","unstructured":"Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000) VEGF is an important stimulator in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41:3158\u20133164","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9402_CR4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","volume":"120","author":"MG Kryzstolik","year":"2002","unstructured":"Kryzstolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NM, Li W, Connolly E, O\u2019Neill CA, Miller JW (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338\u2013346","journal-title":"Arch Ophthalmol"},{"key":"9402_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","volume":"195","author":"Y Saishin","year":"2003","unstructured":"Saishin Y, Saishin Y, Takahashi K, Lima Silva R, Hylton D, Rudge JS, Wiegand SJ, Campochiaro PA (2003) VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 195:241\u2013248","journal-title":"J Cell Physiol"},{"key":"9402_CR6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431","journal-title":"N Engl J Med"},{"key":"9402_CR7","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U, View 1 and View 2 Study Groups (2012) Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration. Ophthalmology 119:2537\u20132548","journal-title":"Ophthalmology"},{"key":"9402_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jcp.20525","volume":"206","author":"SA Vinores","year":"2006","unstructured":"Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, Nambu H, Liu H, Carmeliet P, Campochiaro PA (2006) Implication of the hypoxia response element of the VEGF promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol 206:749\u2013758","journal-title":"J Cell Physiol"},{"key":"9402_CR9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1096\/fj.09-145664","volume":"24","author":"T Yoshida","year":"2010","unstructured":"Yoshida T, Zhang H, Iwase T, Shen J, Semenza G, Campochiaro PA (2010) Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization. FASEB J 24:1759\u20131767","journal-title":"FASEB J"},{"key":"9402_CR10","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.1073\/pnas.0809763105","volume":"105","author":"H Zhang","year":"2008","unstructured":"Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, Dang CV, Liu JO, Semenza GL (2008) Digoxin and other cardiac glycosides inhibit HIF-1alpha sythesis and block tumor growth. Proc Natl Acad Sci USA 105:19579\u201319586","journal-title":"Proc Natl Acad Sci USA"},{"key":"9402_CR11","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1096\/fj.06-7359com","volume":"21","author":"R Lima e Silva","year":"2007","unstructured":"Lima e Silva R, Shen J, Hackett SF, Kachi S, Akiyama H, Kiuchi K, Yokoi K, Hatara C, McLauer T, Aslam S, Gong YY, Xiao WH, Khu NH, Thut C, Campochiaro PA (2007) The SDF-1\/CXCR4 ligand\/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J 21:3219\u20133230","journal-title":"FASEB J"},{"key":"9402_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0014-5793(03)00177-7","volume":"539","author":"P Forrer","year":"2003","unstructured":"Forrer P, Stumpp MT, Binz HK, Pluckthun A (2003) A novel strategy to design binding molecules harnessing the modular nature of repeat proteins. FEBS Lett 539:2\u20136","journal-title":"FEBS Lett"},{"key":"9402_CR13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-2836(03)00896-9","volume":"332","author":"HK Binz","year":"2003","unstructured":"Binz HK, Stumpp MT, Forrer P, Armstutz P, Pluckthun A (2003) Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J Mol Biol 332:489\u2013503","journal-title":"J Mol Biol"},{"key":"9402_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10456-012-9302-0","volume":"16","author":"A Stahl","year":"2013","unstructured":"Stahl A, Stumpp MT, Schlegel A, Ekawardhani S, Lehrling C, Gottfried M, Gulotti-Georgieva M, Villemangne D, Forrer P, Agostini HT, Binz HK (2013) Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications. Angiogenesis 16:101\u2013111","journal-title":"Angiogenesis"},{"key":"9402_CR15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nbt962","volume":"22","author":"HK Binz","year":"2004","unstructured":"Binz HK, Amstutz P, Kohl A, Stumpp MT, Briand C, Forrer P, Grutter MG, Pluckthun A (2004) High-affinity binders selected from designed ankyrin repeat protein libraries. Nat Biotechnol 22:575\u2013582","journal-title":"Nat Biotechnol"},{"key":"9402_CR16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00006982-200308000-00012","volume":"23","author":"JR Heckenlively","year":"2003","unstructured":"Heckenlively JR, Hawes NL, Friedlander M, Nusinowitz S, Hurd R, Davisson M, Chang B (2003) Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 23:518\u2013522","journal-title":"Retina"},{"key":"9402_CR17","first-page":"281","volume":"151","author":"N Okamoto","year":"1997","unstructured":"Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281\u2013291","journal-title":"Am J Pathol"},{"key":"9402_CR18","first-page":"180","volume":"39","author":"T Tobe","year":"1998","unstructured":"Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA (1998) Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39:180\u2013188","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9402_CR19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9440(10)64891-2","volume":"160","author":"K Ohno-Matsui","year":"2002","unstructured":"Ohno-Matsui K, Hirose A, Yamamoto S, Saikia J, Okamoto N, Gehlbach P, Duh EJ, Hackett SF, Chang M, Bok D, Zack DJ, Campochiaro PA (2002) Inducible expression of vascular endothelial growth factor in photoreceptors of adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol 160:711\u2013719","journal-title":"Am J Pathol"},{"key":"9402_CR20","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.ophtha.2009.05.020","volume":"116","author":"K Miki","year":"2009","unstructured":"Miki K, Miki A, Matsuoka M, Muramatsu D, Hackett SF, Campochiaro PA (2009) Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor. Ophthalmology 116:1748\u20131754","journal-title":"Ophthalmology"},{"key":"9402_CR21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","volume":"364","author":"DF Marin","year":"2011","unstructured":"CATT Research Group, Marin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897\u20131908","journal-title":"N Engl J Med"},{"key":"9402_CR22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajo.2012.09.032","volume":"155","author":"PA Campochiaro","year":"2012","unstructured":"Campochiaro PA, Channa R, Berger BB, Heier JS, Brown DM, Fiedler U, Hepp J, Stumpp MT (2012) Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase 1\/2 study. Am J Ophthalmol 155:697\u2013704","journal-title":"Am J Ophthalmol"},{"key":"9402_CR23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0002-9440(10)64612-3","volume":"157","author":"M-S Seo","year":"2000","unstructured":"Seo M-S, Okamoto N, Vinores MA, Vinores SA, Hackett SF, Yamada H, Yamada E, Derevjanik NL, LaRochelle W, Zack DJ, Campochiaro PA (2000) Photoreceptor-specific expression of PDGF-B results in traction retinal detachment. Am J Pathol 157:995\u20131005","journal-title":"Am J Pathol"},{"key":"9402_CR24","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","volume":"168","author":"N Jo","year":"2006","unstructured":"Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT (2006) Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168:2036\u20132053","journal-title":"Am J Pathol"},{"key":"9402_CR25","unstructured":"Boyer DS, Ophthotech Anti-PDGF in AMD Study Group (2009) Combined inhibition of platelet-derived (PDGF) and vascular endothelial (VEGF) growth factors for the treatment of neovascular age-related macular degeneration (NV-AMD). Results of a phase 1 study. Invest Ophthalmol Vis Sci. Online ARVO abstract 1260"},{"key":"9402_CR26","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jmb.2008.07.085","volume":"382","author":"D Steiner","year":"2008","unstructured":"Steiner D, Forrer P, Pluckthun A (2008) Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display. J Mol Biol 382:1211\u20131227","journal-title":"J Mol Biol"},{"key":"9402_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2859-8-8","volume":"8","author":"M Kawe","year":"2009","unstructured":"Kawe M, Horn U, Pluckthun A (2009) Facile promoter deletion in Escherichia coli in response to leaky expression of very robust and benign proteins from common expression vectors. Microb Cell Fact 8:8","journal-title":"Microb Cell Fact"},{"key":"9402_CR28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jim.2006.05.012","volume":"314","author":"T Zimmerman","year":"2006","unstructured":"Zimmerman T, Petit Frere C, Raba M, Weisbach M, Dohn K, Popp A, Donzeau M (2006) Simultaneous metal chelate affinity purification and endotoxin clearance of recombinant antibody fragments. J Immunol Methods 314:67\u201373","journal-title":"J Immunol Methods"},{"key":"9402_CR29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65753-7","volume":"153","author":"T Tobe","year":"1998","unstructured":"Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153:1641\u20131646","journal-title":"Am J Pathol"},{"key":"9402_CR30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1114","volume":"188","author":"K Mori","year":"2001","unstructured":"Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA (2001) Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 188:253\u2013263","journal-title":"J Cell Physiol"},{"key":"9402_CR31","first-page":"101","volume":"35","author":"LEH Smith","year":"1994","unstructured":"Smith LEH, Wesolowski E, McLellan A, Kostyk SK, D\u2019Amato R, Sullivan R, D\u2019Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101\u2013111","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-013-9402-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-013-9402-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-013-9402-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T17:26:28Z","timestamp":1559150788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-013-9402-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":31,"alternative-id":["9402"],"URL":"https:\/\/doi.org\/10.1007\/s10456-013-9402-5","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,24]]}}}